Skip to main content
Year archive

Diasorin — 2022 filings

All 97 regulatory filings released by Diasorin (DIA) in 2022, sourced directly from the official regulator.

97 Filings
2022 Period
2022 filings (97)
Filing Released Lang
Comunicato Internal Dealing
Director's Dealing
2022-12-22 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 02/12/2022- 07/12/2022
Transaction in Own Shares
2022-12-07 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 2/12/2022 - 7/12/2022
Transaction in Own Shares
2022-12-07 Italian
DiaSorin S.p.A. - 2023 Annual Calendar of Corporate Events
Report Publication Announcement
2022-12-01 English
DiaSorin S.p.A. - Calendario Annuale Eventi Societari 2023
Report Publication Announcement
2022-12-01 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2022-11-07 English
Comunicazione ammontare complessivo diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2022-11-07 Italian
DiaSorin 9M 2022 results
Investor Presentation 9M 2022
2022-10-27 English
DiaSorin: Revenue growth and strong profitability in the first 9 months of 2022 - Full year 2022 Guidance revised upwards
Earnings Release 9M 2022
2022-10-27 English
DiaSorin: Ricavi in crescita ed elevata marginalità nei primi 9 mesi del 2022 - Guidance per l’esercizio 2022 rivista al rialzo
Earnings Release 9M 2022
2022-10-27 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 13/09/2022- 19/09/2022
Transaction in Own Shares
2022-09-19 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 13/09/2022-19/09/2022
Transaction in Own Shares
2022-09-19 Italian
DIASORIN SIMPLEXA™ COVID-19 TEST RECEIVED U.S. FDA 510(K) CLEARANCE
Legal Proceedings Report
2022-09-14 English
DiaSorin riceve l'approvazione 510k per il test Simplexa COVID
Regulatory Filings
2022-09-14 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 06/09/2022- 12/09/2022
Transaction in Own Shares
2022-09-12 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 06/09/2022-12/09/2022
Transaction in Own Shares
2022-09-12 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 30/08/2022- 05/09/2022
Transaction in Own Shares
2022-09-05 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 30/08/2022 -05/09/2022
Transaction in Own Shares
2022-09-05 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 23/08/2022- 29/08/2022
Transaction in Own Shares
2022-08-29 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 23/08/2022 -29/08/2022
Transaction in Own Shares
2022-08-29 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 16/08/2022- 22/08/2022
Transaction in Own Shares
2022-08-22 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 16/08/2022 -22/08/2022
Transaction in Own Shares
2022-08-22 English
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 04/08/2022- 12/08/2022
Transaction in Own Shares
2022-08-13 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 04/08/2022 -12/08/2022
Transaction in Own Shares
2022-08-13 Italian
DiaSorin Half-year financial report - June 30, 2022
Interim / Quarterly Report H1 2022
2022-08-09 English
Relazione Finanziaria Semestrale del Gruppo DiaSorin al 30 giugno 2022
Interim / Quarterly Report H1 2022
2022-08-04 Italian
DiaSorin H1 2022 results
Investor Presentation H1 2022
2022-08-03 English
DiaSorin: strong revenues growth in the First Half of 2022 - full Year 2022 Guidance on both Revenues and Profitability revised upwards
Earnings Release H1 2022
2022-08-03 English
DiaSorin: fatturato in forte crescita nel 1° semestre 2022 - guidance per l’esercizio 2022 su ricavi e marginalità rivista al rialzo
Earnings Release H1 2022
2022-08-03 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 18/07/2022- 22/07/2022
Transaction in Own Shares
2022-07-25 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 18/07/2022 -22/07/2022
Transaction in Own Shares
2022-07-25 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 14/06/2022- 17/06/2022
Transaction in Own Shares
2022-06-20 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 14/06/2022 - 17/06/2022
Transaction in Own Shares
2022-06-20 English
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 07/06/2022- 13/06/2022
Transaction in Own Shares
2022-06-13 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 07/06/2022 - 13/06/2022
Transaction in Own Shares
2022-06-13 English
Execution of the project for the redefinition of the corporate structure
Regulatory Filings
2022-06-07 English
Attuazione del progetto di ridefinizione della struttura societaria
AGM Information
2022-06-07 Italian
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 31/05/2022- 06/06/2022
Transaction in Own Shares
2022-06-06 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 31/05/2022 - 06/06/2022
Transaction in Own Shares
2022-06-06 English
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 24/05/2022- 30/05/2022
Transaction in Own Shares
2022-05-30 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 24/05/2022 - 30/05/2022
Transaction in Own Shares
2022-05-30 English
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 13/05/2022 - 23/05/2022
Transaction in Own Shares
2022-05-23 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 13/05/2022 - 23/05/2022
Transaction in Own Shares
2022-05-23 Italian
DiaSorin CE Marks their ARIES® Flu A/B & RSV+SARS-CoV-2 Lowplex Assay
Regulatory Filings
2022-05-20 English
DiaSorin annuncia la marcatura CE del test molecolare ARIES® Flu A/B & RSV+SARS-CoV-2
Environmental & Social Information
2022-05-20 Italian
Pubblicazione del verbale dell'assemblea degli azionisti del 29 aprile 2022
AGM Information
2022-05-11 Italian
Verbale Assemblea Ordinaria degli Azionisti 29 aprile 2022
Declaration of Voting Results & Voting Rights Announcements
2022-05-11 English
Update Annual Calendar of Corporate Events 2022
Report Publication Announcement
2022-05-06 English
Aggiornamento Calendario Annuale Eventi Societari 2022
Report Publication Announcement
2022-05-06 Italian
DiaSorin: Q1 2021 results presentation
Interim / Quarterly Report Q1 2022
2022-05-06 English
DiaSorin: fatturato e generazione di cassa in forte crescita nel 1° trimestre 2022
Earnings Release Q1 2022
2022-05-06 Italian
DiaSorin: strong growth in revenues and cash flow generation in Q1 2022
Earnings Release Q1 2022
2022-05-06 English
Publication of the summary report of the votes cast
AGM Information
2022-05-02 English
Pubblicazione del rendiconto sintetico delle votazioni
Declaration of Voting Results & Voting Rights Announcements
2022-05-02 Italian
DIASORIN S.P.A. SHAREHOLDERS’ MEETING 2022
AGM Information
2022-04-29 English
ASSEMBLEA DEGLI AZIONISTI 2022 - DIASORIN S.P.A.
AGM Information
2022-04-29 Italian
Report on the remuneration policy for the year 2022 and remuneration paid in the year 2021
Remuneration Information
2022-04-26 English
Report on the treasury shares buy-back plan of DiaSorin S.p.A. - Period 21/04/2022- 22/04/2022
Transaction in Own Shares
2022-04-22 English
Informativa sul programma di acquisto di azioni proprie di DiaSorin S.p.A. - Periodo 21/04/2022 - 22/04/2022
Transaction in Own Shares
2022-04-22 Italian
New proposal for resolution related to the remuneration of the Board of Statutory Auditors
Regulatory Filings
2022-04-22 English
Nuova proposta di delibera sui compensi del Collegio Sindacale
AGM Information
2022-04-22 Italian
Annual Financial Report at December 31, 2021
Annual Report FY 2021
2022-04-21 English
RECTIFICATION - Communication on total amount of voting rights.
Declaration of Voting Results & Voting Rights Announcements
2022-04-21 English
ERRATA CORRIGE - Comunicazione ammontare complessivo diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2022-04-21 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2022-04-21 English
Comunicazione ammontare complessivo diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2022-04-21 Italian
Publication of the updated proxy forms for voting through the Designated Representative
Proxy Solicitation & Information Statement
2022-04-13 English
Pubblicazione dei moduli aggiornati per il conferimento della delega al Rappresentante Designato
AGM Information
2022-04-13 Italian
Shareholders' Meeting April 29, 2022 - SPAFID proxy form (art. 135-novies TUF) (UPDATED)
Proxy Solicitation & Information Statement
2022-04-13 English
Assemblea Ordinaria degli Azionisti del 29 aprile 2022 – Modulo delega SPAFID (art. 135-novies TUF) (AGGIORNATO)
Proxy Solicitation & Information Statement
2022-04-13 Italian
Shareholders' Meeting April 29, 2022 - SPAFID proxy form (art. 135-undecies TUF) (UPDATED)
Proxy Solicitation & Information Statement
2022-04-13 English
Assemblea Ordinaria degli Azionisti del 29 aprile 2022 – Modulo delega SPAFID (art. 135-undecies TUF) (AGGIORNATO)
Proxy Solicitation & Information Statement
2022-04-13 Italian
Publication of the lists of candidates for the appointment of the Board of Director, of the Board of Statutory Auditors and resolution proposals
Board/Management Information
2022-04-08 English
Pubblicazione delle liste per la nomina del Consiglio di Amministrazione, del Collegio Sindacale e delle relative proposte di delibera
Board/Management Information
2022-04-08 Italian
Update Annual Calendar of Corporate Events 2022
Report Publication Announcement
2022-04-08 English
Aggiornamento Calendario Annuale Eventi Societari 2022
Report Publication Announcement
2022-04-08 Italian
Pubblicazione della Relazione Finanziaria Annuale e documenti correlati
Report Publication Announcement
2022-04-07 Italian
Relazione sulla politica in materia di remunerazione per l'esercizio 2022 e sui compensi corrisposti nell'esercizio 2021
Remuneration Information
2022-04-07 Italian
Relazione Finanziaria Annuale al 31 dicembre 2021
Annual Report FY 2021
2022-04-07 Italian
NOTICE PURSUANT TO ART. 144-OCTIES, PARA. 2 OF CONSOB REGULATION N. 11971/1999
AGM Information
2022-04-05 English
COMUNICATO AI SENSI DELL’ART. 144-OCTIES, COMMA 2, DEL REGOLAMENTO CONSOB N. 11971/1999
AGM Information
2022-04-05 Italian
DiaSorin S.p.A. - Filing of the lists submitted by IP Investimenti e Partecipazioni S.r.l.
Board/Management Information
2022-04-04 English
DiaSorin S.p.A. – Presentate le liste di IP Investimenti e Partecipazioni S.r.l.
Board/Management Information
2022-04-04 Italian
Shareholders' Meeting April 29, 2022 - Reports and motions for resolutions
Proxy Solicitation & Information Statement
2022-03-30 English
DIASORIN: PUBBLICAZIONE DELLA DOCUMENTAZIONE PER L’ASSEMBLEA ORDINARIA DEL 29 APRILE 2022
AGM Information
2022-03-16 Italian
Assemblea Ordinaria degli Azionisti del 29 aprile 2022 – Modulo delega SPAFID (art. 135-undecies TUF)
Proxy Solicitation & Information Statement
2022-03-16 Italian
Assemblea Ordinaria degli Azionisti del 29 aprile 2022 – Modulo delega SPAFID (art. 135-novies TUF)
AGM Information
2022-03-16 Italian
Assemblea Ordinaria degli Azionisti 29 aprile 2022 – Relazioni Illustrative e proposte di delibera
AGM Information
2022-03-16 Italian
DiaSorin S.p.A. – Ordinary Shareholders’ Meeting April 29, 2022 – Notice
AGM Information
2022-03-16 English
DiaSorin S.p.A. - Assemblea Ordinaria degli Azionisti 29 aprile 2022 – Avviso di convocazione
AGM Information
2022-03-16 Italian
DiaSorin business momentum and the Luminex acquisition drive up revenues, net result and cash flow generation in 2021
Earnings Release FY 2021
2022-03-16 English
DiaSorin FY 2021 Results Presentation
Investor Presentation
2022-03-16 English
La crescita del business DiaSorin e l’acquisizione Luminex trainano l’aumento di ricavi, risultato netto e generazione di cassa nell’esercizio 2021
Earnings Release FY 2021
2022-03-16 Italian
Communication on total amount of voting rights
Declaration of Voting Results & Voting Rights Announcements
2022-02-07 English
Comunicazione ammontare complessivo dei diritti di voto
Declaration of Voting Results & Voting Rights Announcements
2022-02-07 Italian
DiaSorin releases an updated Simplexa™ SARS-CoV-2 Variants Direct molecular assay (RUO)
Regulatory Filings
2022-01-13 English
DiaSorin lancia una nuova versione del test molecolare Simplexa™ SARS-CoV-2 Variants Direct (test ad uso esclusivo di ricerca)
Regulatory Filings
2022-01-13 Italian